10,013 Shares in Haleon PLC Sponsored ADR $HLN Acquired by Verdence Capital Advisors LLC

Verdence Capital Advisors LLC bought a new position in shares of Haleon PLC Sponsored ADR (NYSE:HLN) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 10,013 shares of the company’s stock, valued at approximately $104,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Brighton Jones LLC bought a new position in shares of Haleon in the fourth quarter valued at $187,000. Rhumbline Advisers increased its holdings in shares of Haleon by 6.7% in the first quarter. Rhumbline Advisers now owns 57,527 shares of the company’s stock valued at $592,000 after buying an additional 3,625 shares in the last quarter. Farther Finance Advisors LLC increased its holdings in shares of Haleon by 8.8% in the first quarter. Farther Finance Advisors LLC now owns 12,861 shares of the company’s stock valued at $131,000 after buying an additional 1,041 shares in the last quarter. Wealth Enhancement Advisory Services LLC increased its holdings in shares of Haleon by 18.7% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 94,748 shares of the company’s stock valued at $975,000 after buying an additional 14,935 shares in the last quarter. Finally, Janney Montgomery Scott LLC increased its holdings in shares of Haleon by 4.6% in the first quarter. Janney Montgomery Scott LLC now owns 889,394 shares of the company’s stock valued at $9,152,000 after buying an additional 38,831 shares in the last quarter. Institutional investors own 6.67% of the company’s stock.

Haleon Stock Performance

Haleon stock opened at $9.19 on Friday. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.87 and a quick ratio of 0.63. The company has a market capitalization of $40.92 billion, a price-to-earnings ratio of 23.56, a PEG ratio of 2.68 and a beta of 0.20. Haleon PLC Sponsored ADR has a one year low of $8.71 and a one year high of $11.42. The company’s fifty day moving average price is $9.41 and its two-hundred day moving average price is $10.00.

Haleon Increases Dividend

The firm also recently announced a semi-annual dividend, which was paid on Thursday, September 18th. Shareholders of record on Friday, August 15th were given a dividend of $0.0555 per share. The ex-dividend date of this dividend was Friday, August 15th. This is a positive change from Haleon’s previous semi-annual dividend of $0.05. This represents a yield of 190.0%. Haleon’s dividend payout ratio (DPR) is currently 28.21%.

Analysts Set New Price Targets

Several analysts have issued reports on HLN shares. Weiss Ratings reissued a “hold (c)” rating on shares of Haleon in a research note on Wednesday, October 8th. Wall Street Zen downgraded shares of Haleon from a “buy” rating to a “hold” rating in a research note on Saturday, July 12th. The Goldman Sachs Group raised shares of Haleon from a “neutral” rating to a “buy” rating in a research note on Wednesday, September 10th. Finally, Barclays downgraded shares of Haleon from an “overweight” rating to an “equal weight” rating in a research note on Tuesday, September 16th. One research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat, Haleon has an average rating of “Moderate Buy” and an average target price of $12.33.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.